Innocrin Pharmaceuticals Company Profile: Valuation & Investors

Innocrin Pharmaceuticals Overview

Founded
2014

Status
Out of Business

Employees
10

Latest Deal Type
Out of Business

Innocrin Pharmaceuticals General Information

Description

Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating castration-resistant prostate cancer and are used in other hormonally-driven conditions such as endometriosis or congenital adrenal hyperplasia, thereby enabling hospitals to treat even non-oncologic syndromes caused due to excessive androgen production.

Contact Information

Website

www.innocrinpharma.org

Formerly Known As

Hephestics, Viamet Pharmaceuticals

Ownership Status

Out of Business

Financing Status

Formerly VC-backed

Primary Industry

Drug Discovery

Other Industries

Drug Delivery

Therapeutic Devices

Medical Supplies

Primary Office

4220 Appex Highway 55
Suite 330
Durham, NC 27713
United States

+1 (919) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innocrin Pharmaceuticals Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Status	Stage
4. Out of Business	01-Oct-2019		000.00	Completed	Out of Business
3. Later Stage VC	13-Jul-2017	000	000.00	Completed	Generating Revenue
2. Later Stage VC	20-Apr-2015	$28.1M	$28.1M	Completed	Generating Revenue
1. Accelerator/Incubator				Completed	Startup

To view Innocrin Pharmaceuticals’s complete valuation and funding history, request access »

Innocrin Pharmaceuticals Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating cas

Drug Discovery

Durham, NC

10 As of 2016

000.00

00000000 00 000.00

00000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a

0000000000000

Gaithersburg, MD

00 As of 0000

00000

0000 0000-00-00

00000000 00000

00000000

e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,

0000 000000000

Exton, PA

000 As of 0000

0000

0000 0000-00-00

000000&0 0000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Innocrin Pharmaceuticals Competitors (15)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
NexImmune	Formerly VC-backed	Gaithersburg, MD	00	00000	00000000	00000
000000000	Formerly VC-backed	Exton, PA	000	0000	000000&0	0000
00000000000 000000	Accelerator/Incubator Backed	New York, NY			000000000000
000000 00000000000	Formerly VC-backed	San Diego, CA	00	00000	000000&0	00000
000000 00000000000	Private Equity-Backed	Copenhagen, Denmark	0000		000000000000